Aspect Biosystems develops bioprinted tissue therapeutics to treat serious metabolic and endocrine diseases using AI-powered bioprinting technology.

ThoughtExchange provides an AI-powered engagement and survey platform designed to help educational and corporate leaders in North America gather and analyze stakeholder feedback at scale.